Camilla Veronica Simpson
Login to view DISC.Camilla is a C-level biotech executive with a proven track record of bringing novel products for multiple diseases to global markets. Educated at the University of Galway and the University of London, she is the founding CEO of Zehna Therapeutics, a Cleveland Clinic spin-out developing small molecule inhibitors for CKD and CVD.
She is a member of the Biotech CEO Sisterhood, indicating a passion for connecting with and supporting fellow female executives in her field. Camilla also actively engages with developments in the broader biotech space, sharing updates on strategic alliances within her network.
Unique fact: Camilla co-authored publications on a novel, small molecule inhibitor that slows the loss of kidney function in rat models of Chronic Kidney Disease.
Read the full overview →How Camilla shows up
Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Topics Camilla cares about
Work history
Media appearances
DISC profile (public)
DISC behavioral profile
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
More profiles
Discover additional public profiles from our index.
Search more profiles
Looking for someone else? Search here for anyone.